Spleen Cell Transfers. by the fourth month posttransplantation, although this was not as apparent as that in the unmanipulated MRL lpr/lpr controls. In contrast, MRL lpr/lpr recipients of the MRL +/+ splenocytes had a longer 50% mortality rate (9.7 mo posttransfer) than the unmanipulated MRL lpr/lpr controls (5 too), and developed minor lymphadenopathy. MRL +/+ ---* MRL +/+ recipients had a 50% mortality rate 10.2 mo posttransfer, compared to 17 mo for unmanipulated female +/+ mice. The shorter life span of the former group was attributed to some early deaths, apparently due to pulmonary infections. Unexpectedly, MRL +/+ recipients of MRL lpr/Ipr splenocytes developed a severe wasting syndrome, and died 2-4 mo posttransfer (50% mortality 2.2 mo posttransfer) without the typical lymphadenopathy of the donor strain. In a group of such recipients followed closely, wasting was clinically apparent at ~ 1 mo posttransfer. Histologic Studies. MRL lpr recpients of +/+ lymphoid cells did not develop lpr-associated lymphoproliferation, although their lymphoid organs (spleen, thymus, and lymph nodes) showed varying degrees of immunoblastic changes, with increased numbers of plasmacytoid cells. Interestingly, +/+ recipients of lpr lymphoid cells not only failed to manifest lymphoproliferation, they showed signs of graft histoincompatibility. In the early stages (1-2 wk after engraftment), the +/+ recipients' splenic white pulp contained pycnotic cells, plasma cells, and macrophages ( Fig. 3a) , followed by progressive cellular depletion, complete hyalinization, and fibrosis of the splenic parenchyma by 4-5 mo (Fig. 3 b) . Their thymus, BM, and lymph nodes underwent similar stages of cellular depletion and hyalinization. Other organs showing the histologic changes associated with graft histoincompatibility were the liver, which showed focal fibrinoid necrosis of hepatocytes, and portal triaditis with inflammatory destruction of bile ducts (Fig.  3c) , and the gastrointestinal tract (Fig. 3d) where there was inflammatory infiltration with destruction of the mucosal epithelium. Likewise, the bronchi and the inter-and intralobular ductal epithelium of salivary glands were infiltrated by mononuclear inflammatory cells. At autopsy, these affected organs show fibrosis and sclerosis. (Table II) . At 30 d these mice had ~33% as many, and at 60 d ~0.3% as many splenocytes as at day 15 posttransfer, with a marked decline in Thy-1 + cells. In contrast, the splenic cellularity and frequency of T and B cells remained unaltered in +/+ recipients of +/+ cells.
BM Cell
Histocompatibility Studies. Because of the consistent development of GVHD in +/+ recipients of lpr/lpr BM or spleen cells, possible histocompatibility Means + SD of five individual mice for each time point. * ND, not determined.
incompatible target cells and secondary responses against H-2-compatible allogeneic cells were normal, i.e., killing was substantial in both instances. Yet no primary, and only weak secondary CML between the two MRL lines was recorded; the secondary CML was in no way comparable to the secondary responses seen between these cells and C3H/St cells, which differ at minor histocompatibility loci.
Splenomegaly, tested neonatally, was unremarkable in +/+ recipients of +/+ or lpr/lpr cells. The spleen/body weight ratio between uninjected and injected mice was 0.991:1 for +/+ cells, and 0.994:1 for lpr/lpr cells.
Hemopoietic Precursor Efficiency of lpr/lpr.
To determine whether the runt disease of +/+ recipients of lpr/lpr cells was caused by insufficient numbers of bemopoietic precursors in lpr/lpr BM inocula or by BM resistance phenomena (19) , we counted CFU induced in reciprocal BM cell transfers between the two MRL lines. As shown in Table V , lpr/lpr BM inocula contained sufficient numbers of pluripotent cells; somewhat more, in fact, than in -I-/+ inocula.
Attempts to Overcome the Wasting Syndrome. We used several methods that reportedly (12, (20) (21) (22) prevent GVHD caused by major or minor histocompatibility differences. Treatment of the lpr/lpr BM inocula with anti-Thy-l.2 alone or in conjunction with C to opsonize or eliminate contaminating mature T cells, thymus, and liver cells (1.2 × 108 cells irradiated at 3,000 rad) from 2-mo-old +/+ mice suffering from wasting syndrome were injected intraperitoneally into newborn +/+ mice. Additionally, 1-mo-old +/+ mice were lethally irradiated and reconstituted with +/+ BM cells (2 X 10 7) to which an equal number of cells (irradiated to 3,000 rad) from wasting +/+ mice had been added before transfer. Neither group developed clinical or histologic evidence of wasting, even at 5 mo posttransfer.
To examine the possible generation of cytotoxic or suppressor cells, two experiments were performed: First, spleen cells from mice with GVHD were tested for direct cytotoxicity on recipient and donor target cells in a 4-h 52Cr-release assay. However, at effector/target cell ratios of 100:1, 50:1, and 25:1, spleen cells from mice with GVHD were not cytotoxic to either type of target cells (data not shown). Second, we examined the ability of cells from wasting mice to inhibit mitogenic responses of T and B cells from unmanipulated 2-moold lpr/lpr and +/+ mice (Fig. 4) . Cells from unmanipulated 2-mo-old lpr/lpr mice had lower Con A responses than those from unmanipulated +/+ mice, as previously reported (23), but they showed no significant differences in LPS responsiveness. Cells from wasting +/+ mice had minimal Con A responses, but normal LPS responses. Mixing lpr/lpr with +/+ cells derived from unmanipulated mice had no effect on Con A or LPS responsiveness in either population, since the mixed response was equivalent to the expected sum of the responses by each cell population. In contrast, mixing cells from unmanipulated +/+ or lpr/lpr mice with cells from wasting +/+ mice considerably reduced Con A, but not LPS responsiveness in both cell populations.
With regard to BM resistance phenomena, since NK cell activity matures ontogenically only after the third to fourth week of life (19) The pace at which disease develops in irradiated MRL lpr/lpr mice transplanted with MRL lpr/lpr spleen or BM cells is the same regardless of whether the transferred cells originate from prediseased or diseased donors. Moreover, fetal liver cells induce the typical disease (data not shown). These findings suggest that the active ceil being transferred is the stem cell, and that the age-dependent development of autoimmunity and lymphadenopathy does not result from an accumulation of defects at the stem cell level, i.e., stem cells from MRL lpr/lpr mice of any age are at the same stage of abnormality. Prolonged survival and absence of lymphoid hyperplasia in MRL lpr/lpr recipients of MRL +/+ hemopoietic cells indicate the irrelevance of the Ipr/lpr nonlymphoid environment in this disease. In our previous thymic transplants between these two lines, the thymic genotype was of no consequence to the pace and characteristics of the disease (13), despite the need of a thymus for expression of the lpr/lpr phenotype (13, 25) . Experiments with other types of lupus mice (NZB, BXSB) also showed that the origin of the transplanted cells and not the irradiated recipients' environment is the determining factor in disease development. Thus, in reciprocal spleen and BM cell transfers between the early-life disease-developing male and the late-life disease-developing female BXSB mice, the timing of disease onset is dependent on the sex of the donor and not of the recipient (7) . Similarly, NZB hemopoietic cells transferred into H-2-compatible irradiated normal mice cause autoimmune disease, whereas normal cells transferred into irradiated NZB The lpr gene might promote the appearance ofa GVHD-like disease in at least two ways. First, the Ipr locus may directly control a cell surface antigen. If so, the lpr mutation could result in either a new or defective product or, more likely in light of the unidirectional nature of the GVHD, inability to express a product on the cell surface. Second, the lpr locus might be a regulatory gene that influences one or more other regulatory or structural genes, thereby interfering with, blocking, or altering the expression of their products. As a result, the MRL +/+ cells that do express this putative antigen(s) are recognized as foreign, and stimulate a graft-vs.-host reaction. The fact that MRL +/+ mice could not be rescued from the wasting syndrome by the simultaneous administration of lpr/lpr and +/+ cells would also tend to support this notion. Whatever modifications are introduced by the lpr gene on lymphocyte surfaces, compatibility testing does not reveal them, i.e., lpr/lpr ceils do not evoke in the presence of +/+ cells significant primary or secondary MLR or CML reactions, nor a positive Simonsen splenomegaly assay. Clearly, minor histocompatibility differences cause minimal splenomegaly unless the donors are presensitized (36) . Similarly, cytotoxic reactions to minor histocompatibility antigens are very weak except in secondary responses (37) , but even secondary responses were weak between MRL lpr/lpr and MRL +/+ cells. At any rate, loci outside the H-2 complex have been cited in other examples of runt disease after cell transfers between certain combinations of mice (20, 21, 38) .
GVHD observed after BM transplants between major or minor histocompatibility antigen-mismatched individuals possibly reflects alloaggression mediated not by stem cells or their progeny, but by mature T cells contaminating the spleen (30-35 % T cells) or BM (2-7 % T cells) inocula (20, 21) . The basis of this view is the observation that GVHD does not develop if such inocula have been treated with anti-Thy-1 (22) , anti-Thy-1 plus C (20, 21) , or certain lectins that remove T cells (12) . GVHD also does not appear, even across major histocompatibility complex barriers, if fetal liver cells devoid of T cells have been transferred (39, 40) . In these instances, the T cell precursors maturing in the irradiated hosts' thymic environment are presumably tolerized. However, in the case of the MRL lpr/lpr ~ MRL +/+ transfers, none of these manipulations affected the associated GVHD, for unknown reasons. This runt syndrome may not have been mediated by T cells, considering that thymectomy of the MRL +/+ recipients, although delaying, was not preventative. Alternatively, T cells of the MRL lpr/lpr donor maturing in the MRL +/+ environment may be refractory to tolerance induction, as described in other systems (41, 42) . Of particular interest, education of the MRL lpr/lpr cells in an MRL +/+ thymic environment before transfer to the MRL +/+ recipients, or transfer of MRL lpr/lpr cells into MRL +/+ mice that had been thymectomized and given an MRL lpr/lpr thymus just after birth, did not prevent the GVHD. Apparently, the MRL Ipr/lpr thymic genotype has no unique property that allows the MRL lpr/lpr stem cells to acquire characteristics necessary for the initiation of the graft-vs.-host phenomenon. Furthermore, these data suggest an intrinsic defect in the tolerizability of lpr/lpr stem cells.
The possibility of BM resistance (19) was also considered here. In this phenomenon, grafts of hemopoietic cells fail or grow poorly in certain lethally irradiated allogeneic mice, including F~ hybrid recipients of parental cells (43) . Cudkowitz (44) suggested that special recessive, tissue-specific hemopoietic histocompatibility (Hh) genes, rather than classic histocompatibility genes, determine the fate of hemopoietic grafts. However, further consideration led others to conclude (45) that both class I and class II major histocompatibility genes, and not a special Hh gene, control hemopoietic resistance. The resistance is effected by an unusual host-vs.-graft reaction that is radioresistant, independent of the thymus, and is observed in F1 mice injected with parental cells; these requirements were met in Because runt disease is lethal, and because donor T cells are required for its induction, it has been assumed that it is caused by donor cytotoxic T lymphocytes (46) . However, runt disease also seems to develop via generation of suppressor T cells that inhibit physiologic cell proliferation in lymphohemopoietic tissues (38, 47) . Such suppression caused by graft-vs.-host reactions is nonspecific, since it affects not only hemopoiesis of the recipients, but also that of the donor strain The studies reported here indicate that a difference between two lines of mice at the lpr locus or closely-linked genetic elements results in a unidirectional GVHD-like reaction and runt disease. This type of GVHD may be mediated by a radiosensitive immature T cell in the spleen or BM inocula, since it is not abrogated by elimination of mature cells before transfer, and it can be induced by fetal liver cells. The model described here may be useful in further studies of the immunobiology of GVHD due to non-H-2 products, in understanding the means by which the lpr gene adversely affects lymphocyte regulation and homeostasis, and for identifying the modes of its actions. Summary Hemopoietic ceils have been reciprocally transferred between two lines of mice (MRL lpr/lpr and MRL +/+) that are congenic, differing only at the lpr (lymphoproliferation) and possibly closely linked genes. The lpr strain develops a significantly more severe and fast-paced lupus-like syndrome than +/+ strain, along with a substantially larger lymphoid mass. The results showed that: (a) hemopoietic cells of such mice were sufficient to induce the respective disease phenotypes in lethally irradiated syngeneic recipients; (b) cells of MRL +/+ mice maturing in an MRL lpr/lpr environment essentially retained the disease-producing characteristics of the donor, i.e., they induced late-life lupus without lymphadenopathy; but (c) MRL lpr/lpr cells transferred into irradiated MRL +/+ recipients unexpectedly failed to induce the early-life severe lupus and lymphoid hyperplasia of the donor, instead they caused a severe wasting syndrome resembling, in many respects, graft-vs.-host disease (GVHD). This GVHDlike syndrome developed after transfer of MRL lpr/lpr fetal liver, bone marrow, or spleen cells, and was not abrogated by elimination of T cells from the inocula. Thymectomy of the MRL +/+ recipients retarded, but did not prevent, the wasting disease. The unidirectional nature of this disease suggests that the lpr mutation conferred either a structural or regulatory defect that interferred, blocked, or altered the expression or structure of certain lymphocyte antigen(s). As a result, the MRL +/+ cells that did express this antigen(s) were recognized as foreign, and stimulated a graft-vs.-host reaction. These findings may allow definition of a new kind of rejection phenomenon caused by non-H-2 products, and may extend our understanding of the means by which the lpr gene adversely affects lymphocyte regulation and homeostasis.
